Evidence map›Paper›PMID 29197600›Full record

ArticleThe Journal of infection2018

Alveolar T-helper 17 responses to streptococcus pneumoniae are preserved in ART-untreated and treated HIV-infected Malawian adults.

Chikondi Peno, Dominic H Banda, Ndaru Jambo, Anstead M Kankwatira, Rose D Malamba, Theresa J Allain, Daniela M Ferreira, Robert S Heyderman, David G Russell, Henry C Mwandumba and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Chikondi PenoMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi. Electronic address: cpeno@mlw.mw.
Dominic H BandaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Ndaru JamboMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Anstead M KankwatiraMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Rose D MalambaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi.
Theresa J AllainDepartment of Medicine, University of Malawi College of Medicine, Blantyre, Malawi.
Daniela M FerreiraDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Robert S HeydermanMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; Division of Infection & Immunity, University College, London, UK.
David G RussellDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Henry C MwandumbaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; Department of Medicine, University of Malawi College of Medicine, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
Kondwani C JamboMalawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Malawi College of Medicine, Blantyre, Malawi; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: kjambo@mlw.mw.
University of Liverpool · GBCornell University · USLiverpool School of Tropical Medicine · GBUniversity of Malawi · MW

Funding

Medical Research Council MR/M011569/1Medical Research Council MR/P020526/1Wellcome Trust 088696/Z/09/Z
6 · The paper itself

Abstract

objectiveWe explored if HIV infection is associated with impaired T-Helper 17 responses against Streptococcus pneumoniae in the lung.

methodsWe recruited 30 HIV-uninfected healthy controls, 23 asymptomatic HIV-infected adults not on ART, and 40 asymptomatic HIV-infected adults on ART (Median time 3.5yrs), in whom we collected bronchoalveolar lavage fluid. We measured alveolar CD4

resultsWe found that the proportion of alveolar CD4

conclusionAlveolar Th17 responses against S. pneumoniae are preserved in HIV-infected adults. This suggests that there are other alternative mechanisms that are altered in HIV-infected individuals that render them more susceptible to pneumococcal pneumonia.

Indexed as

AdultBronchoalveolar Lavage FluidCulture MediaFemaleHIV-1HIV InfectionsHumansInterferon-gammaInterleukin-17LamivudineLungMalawiMaleMiddle AgedNevirapinePneumonia, PneumococcalCulture MediaIL17A protein, humanInterferon-gammaInterleukin-17LamivudineNevirapineStavudinestavudine, lamivudine, nevirapine drug combinationARTBAL fluidHIVLungPneumoniaStreptococcus pneumoniaeT helper 17

Identifiers

PMID29197600
PMCPMC5792245
OpenAlexW2772574415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.